Hyperion Defi Inc (HYPD) Stock Price, Quote & News

Company Profile

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in Chin...

Industry: Biotechnology

Sector: Healthcare

Phone: 917 289 1117

Website: hyperiondefi.com

Address:

295 Madison Avenue, Suite 2400, New York, United States

misterbond007 Nov. 14 at 4:50 PM

$HYPD BULL

0 · Reply

Mike827 Nov. 14 at 2:06 PM

$HYPD I’m guessing this will be in the $2.00 range by the end of the day today

1 · Reply

bionicman1969 Nov. 14 at 11:45 AM

$HYPD stock is worth $3.X or less at 1x NAV Strong Sell

0 · Reply

URANIO_ARRICCHITO Nov. 14 at 11:09 AM

$HYPD These positive numbers happen in the very worst possible period... compamy unlucky till the end...

0 · Reply

Diiiii Nov. 14 at 12:02 AM

$HYPD Both the quarterly report figures and the earnings call content were better than expected. There are many positive factors, such as HIP-3 with Felix, the Joint Validator with Kinetiq, and the KNTQ genesis event. If capital inflows into Hyperliquid increase and the HYPE token again reaches a new ATH, the stock price is likely to rise many times over.

0 · Reply

Chingying Nov. 13 at 11:26 PM

$HYPD Inflection point for the brighter future happening now !

0 · Reply

Chingying Nov. 13 at 11:23 PM

$HYPD Amazing earnings and amazing guidance ! E: 0.05 vs (9.07) y/y R: 302.506 K vs 1.625 K y/y Q4 guidance: 475 K ~ 515 K +57% ~ +70% Qtr/ previous Qtr

0 · Reply

Jwa68 Nov. 13 at 10:46 PM

$HYPD Still listening to the call as I post. Pretty darn strong first conference call in my mind and I've heard and set up hundreds of them. CEO and CFO very well spoken. Both clearly very knowledgeable and competent. Importantly, they appear to be very transparent. Great educational listen for anyone who owns shares, or is considering investing. A very differentiated model compared to all the other treasury companies out there in my opinion. DYDD...

0 · Reply

Jwa68 Nov. 13 at 9:07 PM

$HYPD https://ir.hyperiondefi.com/news-releases/news-release-details/hyperion-defi-reports-third-quarter-2025-financial-results/

0 · Reply

Mike827 Nov. 13 at 7:53 PM

$HYPD so basically this is going below a dollar soon and the company will just keep diluting share to stay afloat.

0 · Reply

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Sep 27, 2025, 7:30 AM EDT - 6 weeks ago

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

ALTS MARA MSTR

Sep 25, 2025, 8:00 AM EDT - 7 weeks ago

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Sep 16, 2025, 8:00 AM EDT - 2 months ago

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Aug 14, 2025, 10:16 AM EDT - 3 months ago

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Aug 13, 2025, 4:01 PM EDT - 3 months ago

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Aug 8, 2025, 4:05 PM EDT - 3 months ago

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Jul 28, 2025, 8:00 AM EDT - 3 months ago

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Jul 17, 2025, 8:00 AM EDT - 4 months ago

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Jul 14, 2025, 4:05 PM EDT - 4 months ago

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Jun 18, 2025, 2:04 PM EDT - 5 months ago

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

KIDZ LGHL VVPR

Jun 18, 2025, 8:32 AM EDT - 5 months ago

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Jun 17, 2025, 3:54 PM EDT - 5 months ago

Eyenovia Surges on Crypto Announcement

Jun 17, 2025, 2:55 PM EDT - 5 months ago

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

May 19, 2025, 5:30 PM EDT - 6 months ago

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Apr 10, 2025, 7:00 AM EDT - 7 months ago

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Mar 20, 2025, 7:00 AM EDT - 8 months ago

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Feb 26, 2025, 7:00 AM EST - 9 months ago

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Feb 24, 2025, 7:00 AM EST - 9 months ago

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Feb 5, 2025, 7:00 AM EST - 10 months ago

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Jan 28, 2025, 4:05 PM EST - 10 months ago

Eyenovia Announces 1-for-80 Reverse Stock Split

Jan 15, 2025, 7:00 AM EST - 10 months ago

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Jan 6, 2025, 7:00 AM EST - 11 months ago

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Dec 6, 2024, 8:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Nov 22, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Restructuring Efforts

Nov 15, 2024, 1:15 PM EST - 1 year ago

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Nov 15, 2024, 7:07 AM EST - 1 year ago

Eyenovia to discontinue late-stage study for eye drug

Nov 15, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Nov 12, 2024, 10:42 PM EST - 1 year ago

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 1 year ago

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Oct 1, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Sep 27, 2024, 8:30 AM EDT - 1 year ago

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Sep 9, 2024, 3:00 AM EDT - 1 year ago

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Aug 23, 2024, 11:42 AM EDT - 1 year ago

Eyenovia Announces Closing of Public Offering

Aug 22, 2024, 2:20 PM EDT - 1 year ago

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Aug 21, 2024, 9:29 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5.14 Million Public Offering

Aug 20, 2024, 5:09 PM EDT - 1 year ago

Eyenovia, Inc. Announces Proposed Public Offering

Aug 12, 2024, 11:07 PM EDT - 1 year ago

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Aug 7, 2024, 5:11 PM EDT - 1 year ago

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

NBY

Jun 28, 2024, 8:00 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5M Registered Direct Offering

misterbond007 Nov. 14 at 4:50 PM

$HYPD BULL

0 · Reply

Mike827 Nov. 14 at 2:06 PM

$HYPD I’m guessing this will be in the $2.00 range by the end of the day today

1 · Reply

bionicman1969 Nov. 14 at 11:45 AM

$HYPD stock is worth $3.X or less at 1x NAV Strong Sell

0 · Reply

URANIO_ARRICCHITO Nov. 14 at 11:09 AM

$HYPD These positive numbers happen in the very worst possible period... compamy unlucky till the end...

0 · Reply

Diiiii Nov. 14 at 12:02 AM

0 · Reply

Chingying Nov. 13 at 11:26 PM

$HYPD Inflection point for the brighter future happening now !

0 · Reply

Chingying Nov. 13 at 11:23 PM

$HYPD Amazing earnings and amazing guidance ! E: 0.05 vs (9.07) y/y R: 302.506 K vs 1.625 K y/y Q4 guidance: 475 K ~ 515 K +57% ~ +70% Qtr/ previous Qtr

0 · Reply

Jwa68 Nov. 13 at 10:46 PM

0 · Reply

Jwa68 Nov. 13 at 9:07 PM

$HYPD https://ir.hyperiondefi.com/news-releases/news-release-details/hyperion-defi-reports-third-quarter-2025-financial-results/

0 · Reply

Mike827 Nov. 13 at 7:53 PM

$HYPD so basically this is going below a dollar soon and the company will just keep diluting share to stay afloat.

0 · Reply

THESTOCKMARKETOUTLET Nov. 12 at 5:40 PM

$CYPH same setup as $HYPD

0 · Reply

CartB4Horse Nov. 12 at 5:18 PM

$HYPD What should we reasonably expect from the quarterly report?

1 · Reply

LoneBroker Nov. 12 at 4:06 AM

$HYPD • $5.7 🐻 • RSI 40.01 • ATR 14.65% • vol↓ Support & Resistance — UPDATED 11/11/2025 5 Days | Support: $5.28 – $5.28 | Resistance: $6.48 – $6.51 20 Days | Support: $5.28 – $5.28 | Resistance: $9.13 – $9.18 60 Days | Support: $5.28 – $5.28 | Resistance: $15.00 – $15.07 HYPD remains range-bound with RSI near neutral, implying consolidation. Volatility is high, with wider daily price moves expected. Falling volume points to waning interest. Key support and resistance zones should be monitored for direction changes. 📌 RSI = momentum (0–100). >50 = strength, <50 = weakness 📌 ATR% = daily volatility (higher = bigger swings) 📌 Legend: 🐂 bullish • 🐻 bearish • 😐 neutral • vol↑ rising volume • vol↓ easing volume ⏳ Valid until: 4:00 PM ET

0 · Reply

Diiiii Nov. 12 at 2:37 AM

$HYPD It's too early to label this company garbage. To begin with, DATs in general are highly volatile, and HYPE in particular is a new token that's only been around for about a year. It's a microcap with a small number of shares issued, and most of the assets are in HYPE. Current positions in the $5 range may become many times more valuable later, or they may become a true garbage stock that continues to fall further.

0 · Reply

Mike827 Nov. 11 at 7:47 PM

$HYPD this company was garbage as eyenovia and is garbage now. the crypto kid in charge now is incompetent

1 · Reply

LoneBroker Nov. 11 at 12:31 AM

$HYPD $CBRL HYPD • $5.83 🐻 • RSI 38.45 • ATR 14.56% • vol↑ Support & Resistance — UPDATED 11/10/2025 5 Days | Support: $5.28 – $5.70 | Resistance: $5.95 – $6.51 20 Days | Support: $5.28 – $8.04 | Resistance: $5.95 – $9.18 60 Days | Support: $5.28 – $11.75 | Resistance: $5.95 – $15.07 HYPD weakens slightly, reflecting short-term pressure. Volatility is elevated. Volume supports the trend. Key support lies between $5.28–$5.70, with resistance near $5.95–$6.51. CBRL • $29.09 🐻 • RSI 15.27 • ATR 5.42% • vol↑ Support & Resistance — UPDATED 11/10/2025 5 Days | Support: $29.04 – $32.00 | Resistance: $32.07 – $33.50 20 Days | Support: $29.04 – $40.85 | Resistance: $32.07 – $43.36 60 Days | Support: $29.04 – $59.46 | Resistance: $32.07 – $63.47 CBRL weakens slightly, reflecting short-term pressure. Volatility is elevated. Volume supports the trend. Key support lies between $29.04–$32.00, with resistance near $32.07–$33.50. ⏳ Valid until: 4:00 PM ET

0 · Reply

Drewcifer99 Nov. 11 at 12:28 AM

$HYPD what ceo left???

0 · Reply

ontemp Nov. 10 at 10:24 PM

$HYPD The elliott waves on this stock are incredible. 1700% gain in 85 days. Just gotta wait for an impulse wave to come.

0 · Reply

SpencerF Nov. 10 at 6:52 PM

$HYPD safe to dump? Or still a chance the company could make it?

1 · Reply

ontemp Nov. 10 at 3:41 AM

$HYPD Why did the CEO resign? He must have not believed in the vision.

2 · Reply

misterbond007 Nov. 9 at 5:59 PM

$HYPD Back too 3.25 before the big move

0 · Reply

MitchOnX Nov. 9 at 2:06 PM

$HYPD $HYPD Hyperion DeFi Inc. - 60 Second Analysis - November 9, 2025 #HYPD #... https://youtu.be/3uNrQNcGlpY?si=GwdGXm1CZiugPC7G via @YouTube

0 · Reply

Market Cap	37.51M
Revenue (ttm)	60,000.00
Net Income (ttm)	-49.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-83,033.33%
Debt to Equity Ratio	-0.96

Volume	251,835
Avg Vol	831,892
Day's Range	N/A - N/A
Shares Out	6.96M
Stochastic %K	7%
Beta	2.57
Analysts	Strong Buy
Price Target	N/A